<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Arch Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">Arch Med Sci</journal-id><journal-id journal-id-type="publisher-id">AMS</journal-id><journal-title-group><journal-title>Archives of Medical Science : AMS</journal-title></journal-title-group><issn pub-type="ppub">1734-1922</issn><issn pub-type="epub">1896-9151</issn><publisher><publisher-name>Termedia Publishing House</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26788081</article-id><article-id pub-id-type="pmc">4697054</article-id><article-id pub-id-type="publisher-id">26367</article-id><article-id pub-id-type="doi">10.5114/aoms.2015.56346</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Research</subject></subj-group></article-categories><title-group><article-title>Influence of home-based telemonitored Nordic walking training on autonomic nervous system balance in heart failure patients</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Piotrowicz</surname><given-names>Ewa</given-names></name><xref ref-type="aff" rid="AF0001">1</xref></contrib><contrib contrib-type="author"><name><surname>Buchner</surname><given-names>Teodor</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Piotrowski</surname><given-names>Walerian</given-names></name><xref ref-type="aff" rid="AF0003">3</xref></contrib><contrib contrib-type="author"><name><surname>Piotrowicz</surname><given-names>Ryszard</given-names></name><xref ref-type="aff" rid="AF0004">4</xref></contrib></contrib-group><aff id="AF0001"><label>1</label>Telecardiology Centre, Institute of Cardiology, Warsaw, Poland</aff><aff id="AF0002"><label>2</label>Faculty of Physics, Warsaw University of Technology, Warsaw, Poland</aff><aff id="AF0003"><label>3</label>Statistics Laboratory, Institute of Cardiology, Warsaw, Poland</aff><aff id="AF0004"><label>4</label>Department of Cardiac Rehabilitation and Non-invasive Electrocardiology, Institute of Cardiology, Warsaw, Poland</aff><author-notes><corresp id="cor1"><bold>Corresponding author:</bold> Dr. Ewa Piotrowicz, Telecardiology Centre Institute of Cardiology, 42 Alpejska St, 04-628 Warsaw, Poland. Phone: +48 22 343 46 64. E-mail: <email xlink:href="epiotrowicz@ikard.pl">epiotrowicz@ikard.pl</email></corresp></author-notes><pub-date pub-type="epub"><day>11</day><month>12</month><year>2015</year></pub-date><pub-date pub-type="ppub"><day>10</day><month>12</month><year>2015</year></pub-date><volume>11</volume><issue>6</issue><fpage>1205</fpage><lpage>1212</lpage><history><date date-type="received"><day>14</day><month>9</month><year>2014</year></date><date date-type="accepted"><day>16</day><month>9</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2015 Termedia &#x00026; Banach</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.</license-p></license></permissions><abstract><sec id="st1"><title>Introduction</title><p>Rehabilitation positively affects the modulation of the autonomic nervous system (ANS). There are no papers evaluating the influence of Nordic walking training (NW) on ANS activity among chronic heart failure (CHF) patients. The aim of study was to assess the influence of NW on ANS activity measured by heart rate variability (HRV) and heart rate turbulence (HRT) in CHF patients and its correlation with physical capacity improvement measured by peak oxygen consumption (peak VO<sub>2</sub> [ml/kg/min]) in the cardiopulmonary exercise treadmill test (CPET).</p></sec><sec id="st2"><title>Material and methods</title><p>The study group comprised 111 CHF patients (NYHA class II&#x02013;III; ejection fraction (EF) &#x02264; 40%). Patients were randomized (2 : 1) to 8-week NW (five times weekly) at 40&#x02013;70% of maximal heart rate (training group &#x02013; TG) (<italic>n</italic> = 77), or to a control group (CG) (<italic>n</italic> = 34). The effectiveness of NW was assessed by changes (delta (&#x00394;)) in peak VO<sub>2</sub>, HRV and HRT as a result of comparing these parameters from the beginning and the end of the programme.</p></sec><sec id="st3"><title>Results</title><p>Eventually, 36 TG patients and 15 CG patients were eligible for HRV and HRT analysis. In the TG low/high frequency ratio (LF/HF) decreased (1.9 &#x000b1;1.11 vs. 1.7 &#x000b1;0.63, <italic>p</italic> = 0.0001) and peak VO<sub>2</sub> increased (16.98 &#x000b1;4.02 vs. 19.70 &#x000b1;4.36 ml/kg/min, <italic>p</italic> &#x0003c; 0.0001). Favourable results in CG were not observed. The differences between TG and CG were significant: &#x00394;peak VO<sub>2</sub> (<italic>p</italic> = 0.0081); &#x00394;LF/HF (<italic>p</italic> = 0.0038). An inverse correlation was found between the decrease in &#x00394;LF/HF and the increase in &#x00394;peak VO<sub>2</sub> (<italic>R</italic> = &#x02013;0.3830, <italic>p</italic> = 0.0211) only in the TG. Heart rate variability did not change significantly in either group.</p></sec><sec id="st4"><title>Conclusions</title><p>Nordic walking positively affects the parasympathetic-sympathetic balance in CHF patients, which correlates with the improvement in &#x00394;peak VO<sub>2</sub>. No significant influence of NW on HRT was observed.</p></sec></abstract><kwd-group><kwd>exercise training</kwd><kwd>autonomic nervous system</kwd><kwd>heart rate variability</kwd><kwd>heart failure</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="S0001"><title>Introduction</title><p>Deranged autonomic nervous system (ANS) balance constitutes one of the numerous elements of the complex pathophysiological chronic heart failure (CHF) [<xref rid="CIT0001" ref-type="bibr">1</xref>&#x02013;<xref rid="CIT0004" ref-type="bibr">4</xref>]. Most published studies indicate that well-planned exercise training, apart from improving the physical capacity, is also capable of positively affecting the modulation of the majority of parameters (although not necessarily the same ones) which reflect the ANS activity in CHF patients [<xref rid="CIT0005" ref-type="bibr">5</xref>&#x02013;<xref rid="CIT0007" ref-type="bibr">7</xref>]. This results from the fact that different exercise training modalities have been applied in the existing studies. There are no papers evaluating the influence of telerehabilitation based on Nordic walking training on ANS activity in CHF patients. It needs to be stressed that during the Nordic walking training, patients use the majority of their muscles and obtain fitness building stimulation not present in cycling or simple walking training [<xref rid="CIT0008" ref-type="bibr">8</xref>]. Moreover, during this type of training patients also added a small resistance training component in the form of &#x0201c;grip and release&#x0201d; poles [<xref rid="CIT0008" ref-type="bibr">8</xref>]. Additionally, breathing and light stretching exercises in between Nordic walking sessions can be performed. The non-invasive assessment of indices reflecting ANS activity on the surface electrocardiogram (ECG) allow one to evaluate the efficacy of Nordic walking training in terms of sympathetic and parasympathetic balance [<xref rid="CIT0009" ref-type="bibr">9</xref>]. Therefore, the aim of this study was to assess the influence of Nordic walking training on ANS activity measured by heart rate variability (HRV) and heart rate turbulence (HRT) in CHF patients and its correlation with physical capacity improvement measured by peak oxygen consumption (peak VO<sub>2</sub>) evaluated in the cardiopulmonary exercise treadmill test (CPET).</p></sec><sec sec-type="material|methods" id="S0002"><title>Material and methods</title><p>The present study formed part of a single-centre, prospective, parallel-group, randomized (2 : 1), controlled trial of home-based telemonitored Nordic walking training (training group (TG)) vs. usual care (control group (CG)) in CHF patients [<xref rid="CIT0010" ref-type="bibr">10</xref>] who also met the criteria for HRV and HRT evaluation. For this study, we recruited consecutive patients hospitalized between December 2009 and June 2012 in the Department of Cardiac Rehabilitation, Institute of Cardiology, Warsaw, Poland for inclusion in the cardiac rehabilitation. The study was approved by the local Ethics Committee. Each patient gave written informed consent.</p><p>We included: patients of either sex with any aetiology of left ventricular systolic CHF as defined in the European Society of Cardiology (ESC) guidelines [<xref rid="CIT0001" ref-type="bibr">1</xref>] diagnosed at least for 3 months; with a left ventricular ejection fraction (LVEF) &#x0003c; 40% on echocardiography; classified by the New York Heart Association (NYHA) as class II or III; who were clinically stable and receiving an optimal and stable medication regimen for at least 4 weeks before enrolment; who had no contraindications to exercise training according to current recommendation for CHF patients [<xref rid="CIT0011" ref-type="bibr">11</xref>].</p><p>The exclusion criteria were: a history of an acute coronary syndrome within the last month, coronary artery bypass grafting (CABG) within the last 2 months, or initiation of cardiac resynchronization therapy within the last 6 months, or implantation of a pacemaker and/or implantable cardioverter-defibrillator (ICD) within the last 6 weeks; symptomatic and/or exercise-induced cardiac arrhythmia or conduction disturbances; valvular or congenital heart disease requiring surgical treatment; hypertrophic cardiomyopathy; severe pulmonary hypertension or other severe pulmonary disease; uncontrolled hypertension; anaemia; acute and/or decompensated non-cardiac disease; physical disability related to severe musculoskeletal or neurological problems; patient refusal to participate.</p><p>Autonomic nervous system activity assessment was conducted in the eligible patients who were in sinus rhythm. The exclusion criteria were: atrial fibrillation or flutter, atrial and/or ventricular pacing.</p><p>The qualified patients in both groups underwent the following assessments at entry and after completing the 8-week programme: clinical examination, two-dimensional echocardiography, 24-hour Holter ECG monitoring with HRV and HRT evaluation, and CPET.</p><sec id="S20003"><title>Echocardiography</title><p>Two-dimensional echocardiography was performed using standard parasternal, apical, and subcostal views (VIVID 4 GE Medical System with a 2.5 MHz transducer). Left ventricular ejection fraction was calculated from conventional apical two-chamber and four-chamber images using the biplane Simpson technique.</p></sec><sec id="S20004"><title>24-hour Holter ECG monitoring and indices of autonomic nervous system activity analysis</title><p>The HRV and HRT were measured using a 24-hour Holter ECG, recorded with a 3-channel Spacelabs Lifecard system (Spacelabs, Del Mar Reynolds, Hertford, UK). The HRV indices were calculated after prospective interactive ECG analysis, using the Impresario Space software (Del Mar Reynolds). The measurements of HRV included time domain &#x02013; standard deviation of all normal RR intervals (SDNN) &#x02013; and frequency domain indices.</p><p>The frequency domain indices were calculated after fast Fourier transformation of five 10-minute ECG segments, recorded between 2 a.m. and 6 a.m. The highest and lowest values were excluded, and the three remaining values were averaged. The power spectrum density of low frequency (LF) 0.04&#x02013;0.15 Hz, high frequency (HF) 0.15&#x02013;0.4 Hz, and the low frequency to high frequency ratio (LF/HF) was calculated using standard methodology [<xref rid="CIT0009" ref-type="bibr">9</xref>].</p><p>The measurements of HRT included turbulence onset (TO) and turbulence slope (TS) according to the algorithm described by Schmidt <italic>et al</italic>. [<xref rid="CIT0012" ref-type="bibr">12</xref>]. Parameters of HRT were considered normal when TO &#x0003c; 0%, and TS &#x0003e; 2.5 ms/RR interval. The influence of Nordic walking training on ANS activity was assessed by changes (delta) in SDNN, LF, HF, LF/HF ratio, TO and TS resulting from the comparison of these parameters from the beginning and the end of the programme.</p></sec><sec id="S20005"><title>Cardiopulmonary exercise treadmill test</title><p>The symptom limited CPET according to a ramp protocol [<xref rid="CIT0013" ref-type="bibr">13</xref>] and ESC guidelines [<xref rid="CIT0014" ref-type="bibr">14</xref>] was performed using a Schiller treadmill (Carrollton, USA) which was connected to a computerized breath-by-breath spiroergometry system (ZAN 600, ZAN Messger&#x000e4;te GmbH, Germany). Oxygen consumption was measured continuously using breath-by-breath analysis and used as an index of exercise capacity. Peak VO<sub>2</sub> was defined as the highest oxygen uptake level achieved during the final 30 s of CPET.</p></sec><sec id="S20006"><title>Exercise training</title><p>Exercise training was planned in line with the current guidelines for CHF patients [<xref rid="CIT0011" ref-type="bibr">11</xref>]. The chosen workload reflected individual effort tolerance with regard to: perceived exertion according to the Borg scale [<xref rid="CIT0015" ref-type="bibr">15</xref>] and the training heart rate (HR) range established individually for each patient. The training HR was calculated using the method known as HR reserve. This method uses a percentage of the difference between the maximum HR and the resting HR rate, and adds this value to the resting HR. The target training HR was 40&#x02013;70% of the HR reserve. Following the baseline evaluation, patients underwent some (3&#x02013;6) monitored educational exercise training sessions. Subsequently, patients underwent an 8-week home-based telerehabilitation programme. The training session consisted of three parts: a warm-up lasting 5&#x02013;10 min (breathing and light resistance exercises, calisthenics), a 15&#x02013;45 min Nordic walking training, and a 5-minute cool-down. The initial duration of the aerobic Nordic walking training depended on the functional capacity in baseline CPET. If baseline peak VO<sub>2</sub> was &#x0003c; 14 ml/kg/min, we started at 10 min of Nordic walking/day, if baseline peak VO<sub>2</sub> was 14&#x02013;20 ml/kg/min, we started at 15 min of Nordic walking/day; and if baseline peak VO<sub>2</sub> was &#x0003e; 20 ml/kg/min, we started at 20 min of Nordic walking/day. Later on we tended to gradually prolong the time allotted to training so that the final period of time would reach 45&#x02013;60 min. In order to achieve this optimal prolonged training duration usually 2 weeks needed to elapse. Patients trained five times a week.</p><p>The exercise training effectiveness was assessed by changes (delta) in peak VO<sub>2</sub> in CPET, resulting from the comparison of these parameters from the beginning and the end of the programme. The methodology of the telerehabilitation model was described previously [<xref rid="CIT0016" ref-type="bibr">16</xref>&#x02013;<xref rid="CIT0018" ref-type="bibr">18</xref>].</p><p>In brief, all patients in the TG received a special remote device for ECG and telesupervised exercise training &#x02013; the telerehabilitation set (Pro Plus Company, Poland), which consists of: an EHO mini device and blood pressure measuring and weighing machine. The EHO mini device enabled the ECG data from three pre-cordial leads to be recorded and transmitted via a mobile phone to the monitoring centre.</p></sec><sec id="S20007"><title>Usual care</title><p>Patients in CG receiving &#x0201c;usual care&#x0201d; did not receive a formal exercise training prescription and did not undergo supervised rehabilitation. All patients, independent from the treatment group, were given recommendations for appropriate lifestyle changes and self-management according to ESC guidelines [<xref rid="CIT0001" ref-type="bibr">1</xref>].</p></sec><sec id="S20008"><title>Statistical analysis</title><p>Statistical analyses were performed using SAS software (version 9.2; Cary, NC, USA). The normality of distributions was verified using the Shapiro-Wilk test. To compare normally distributed continuous variables, paired and unpaired <italic>t-</italic>tests were used. To compare changes of variables in time between training and control groups the general linear model with repeated measures adjusted for age and NYHA class was used. The signed-rank test (for changes over time) and the Wilcoxon test (to compare groups) were used for continuous variables that were not distributed normally. Correlations between peak VO<sub>2</sub> and LF/HF ratio changes were tested with the Spearman-Pearson test. The &#x003c7;<sup>2</sup> or Fisher exact test was used for categorical variables. Values of <italic>p</italic> &#x0003c; 0.05 were considered significant.</p></sec></sec><sec sec-type="results" id="S0009"><title>Results</title><p>Of the 111 patients randomized, 77 were assigned to the TG and 34 to the CG. Thirty-six patients in the TG and 15 patients in the CG were eligible for HRV analysis. The groups were comparable in terms of demographic data, baseline clinical parameters and pharmacotherapy except for age and NYHA class. It needs to be stressed that all patients were treated with a &#x003b2;-blocker. The baseline clinical characteristics of patients are shown in <xref ref-type="table" rid="T0001">Table I</xref>.</p><table-wrap id="T0001" position="float"><label>Table I</label><caption><p>Baseline characteristics</p></caption><table frame="border" rules="rows" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1">Characteristics</th><th align="center" rowspan="1" colspan="1">Training group (<italic>n</italic> = 36)</th><th align="center" rowspan="1" colspan="1">Control group (<italic>n</italic> = 15)</th><th align="center" rowspan="1" colspan="1">Value of <italic>p</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Males</td><td align="center" rowspan="1" colspan="1">31 (86)</td><td align="center" rowspan="1" colspan="1">15 (100)</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">Age [years]</td><td align="center" rowspan="1" colspan="1">52.6 &#x000b1;10.12</td><td align="center" rowspan="1" colspan="1">61.4 &#x000b1;13.2</td><td align="center" rowspan="1" colspan="1">0.0205</td></tr><tr><td align="left" rowspan="1" colspan="1">Left ventricular ejection fraction (%)</td><td align="center" rowspan="1" colspan="1">32 &#x000b1;7</td><td align="center" rowspan="1" colspan="1">33 &#x000b1;8</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">Etiology of heart failure:</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Ischaemic</td><td align="center" rowspan="1" colspan="1">25 (69.4)</td><td align="center" rowspan="1" colspan="1">12 (80.0)</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Non-ischaemic</td><td align="center" rowspan="1" colspan="1">11 (30.6)</td><td align="center" rowspan="1" colspan="1">3 (20.0)</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">Past medical history:</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Myocardial infarction</td><td align="center" rowspan="1" colspan="1">24 (66.7)</td><td align="center" rowspan="1" colspan="1">12 (80.0)</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Angioplasty</td><td align="center" rowspan="1" colspan="1">18 (50.0)</td><td align="center" rowspan="1" colspan="1">10 (66.7)</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Coronary artery bypass grafting</td><td align="center" rowspan="1" colspan="1">6 (11.8)</td><td align="center" rowspan="1" colspan="1">4 (26.7)</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Stroke</td><td align="center" rowspan="1" colspan="1">1 (2.9)</td><td align="center" rowspan="1" colspan="1">1 (6.7)</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Diabetes</td><td align="center" rowspan="1" colspan="1">8 (22.2)</td><td align="center" rowspan="1" colspan="1">4 (26.67)</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Hyperlipidaemia</td><td align="center" rowspan="1" colspan="1">19 (52.8)</td><td align="center" rowspan="1" colspan="1">8 (53.3)</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">Functional status:</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;NYHA II</td><td align="center" rowspan="1" colspan="1">32 (88.9)</td><td align="center" rowspan="1" colspan="1">8 (53.3)</td><td align="center" rowspan="1" colspan="1">0.009</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;NYHA III</td><td align="center" rowspan="1" colspan="1">4 (11.1)</td><td align="center" rowspan="1" colspan="1">7 (46.7)</td><td align="center" rowspan="1" colspan="1">0.009</td></tr><tr><td align="left" rowspan="1" colspan="1">Heart rate variability:</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;SDNN [ms]</td><td align="center" rowspan="1" colspan="1">118 &#x000b1;30</td><td align="center" rowspan="1" colspan="1">124 &#x000b1;32</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Low frequency [ms<sup>2</sup>/Hz]</td><td align="center" rowspan="1" colspan="1">532 &#x000b1;601</td><td align="center" rowspan="1" colspan="1">339 &#x000b1;211</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;High frequency [ms<sup>2</sup>/Hz]</td><td align="center" rowspan="1" colspan="1">392 &#x000b1;493</td><td align="center" rowspan="1" colspan="1">225 &#x000b1;154</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Low-to-high frequency ratio</td><td align="center" rowspan="1" colspan="1">1.91 &#x000b1;1.11</td><td align="center" rowspan="1" colspan="1">2.2 &#x000b1;1.6</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">Heart rate turbulence:</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Turbulence onset (%)</td><td align="center" rowspan="1" colspan="1">&#x02013;1.51 &#x000b1;3.12</td><td align="center" rowspan="1" colspan="1">&#x02013;1.31 &#x000b1;1.13</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Turbulence slope [ms/RR interval]</td><td align="center" rowspan="1" colspan="1">9.04 &#x000b1;10.29</td><td align="center" rowspan="1" colspan="1">5.43 &#x000b1;5.01</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">Cardiopulmonary exercise test:</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Peak VO<sub>2</sub> [ml/kg/min]</td><td align="center" rowspan="1" colspan="1">16.98 &#x000b1;4.02</td><td align="center" rowspan="1" colspan="1">17.90 &#x000b1;3.61</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">Treatment:</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x003b2;-Blocker</td><td align="center" rowspan="1" colspan="1">36 (100)</td><td align="center" rowspan="1" colspan="1">15 (100)</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Angiotensin converting enzyme inhibitors</td><td align="center" rowspan="1" colspan="1">32 (88.9)</td><td align="center" rowspan="1" colspan="1">13 (86.7)</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Angiotensin receptor blockers</td><td align="center" rowspan="1" colspan="1">4 (11.1)</td><td align="center" rowspan="1" colspan="1">1 (6.7)</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Loop diuretics</td><td align="center" rowspan="1" colspan="1">19 (52.8)</td><td align="center" rowspan="1" colspan="1">8 (53.3)</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Aspirin</td><td align="center" rowspan="1" colspan="1">29 (80.6)</td><td align="center" rowspan="1" colspan="1">11 (73.3)</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Anticoagulants</td><td align="center" rowspan="1" colspan="1">8 (22.2)</td><td align="center" rowspan="1" colspan="1">4 (26.7)</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Statins</td><td align="center" rowspan="1" colspan="1">28 (77.8)</td><td align="center" rowspan="1" colspan="1">11 (73.3)</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Implantable cardioverter-defibrillator</td><td align="center" rowspan="1" colspan="1">24 (66.7)</td><td align="center" rowspan="1" colspan="1">9 (60.0)</td><td align="center" rowspan="1" colspan="1">NS</td></tr></tbody></table><table-wrap-foot><fn><p>Data presented are mean &#x000b1; SD or n (%), NS &#x02013; non-significant, NYHA &#x02013; New York Heart Association class, SDNN &#x02013; standard deviation of all normal RR intervals, peak VO<sub>2</sub> &#x02013; peak oxygen consumption.</p></fn></table-wrap-foot></table-wrap><sec id="S20010"><title>Effects of Nordic walking training on autonomic nervous system indices</title><p>There was a significant improvement in sympathovagal balance evaluated by LF/HF ratio only in the TG (<italic>p</italic> = 0.0001), which was statistically significant in between-group analysis after adjustment for age and NYHA class (<italic>p</italic> = 0.0038). The HRT did not change significantly in either group. The details are presented in <xref ref-type="table" rid="T0002">Table II</xref>.</p><table-wrap id="T0002" position="float"><label>Table II</label><caption><p>Comparison of outcomes before and after telerehabilitation based on Nordic walking training in the training group (<italic>p</italic><sup>1</sup>) and before and after observation in the control group (<italic>p</italic><sup>2</sup>) and between groups &#x02013; group &#x000d7; time adjusted for age and New York Heart Association class (<italic>p</italic><sup>3</sup>)</p></caption><table frame="border" rules="rows" width="100%"><thead><tr><th align="left" valign="top" rowspan="2" colspan="1">Parameter</th><th align="center" colspan="3" rowspan="1">Training group</th><th align="center" colspan="3" rowspan="1">Control group</th><th align="center" valign="top" rowspan="2" colspan="1">Value of <italic>p</italic><sup>3</sup></th></tr><tr><th align="center" rowspan="1" colspan="1">Before training</th><th align="center" rowspan="1" colspan="1">After training</th><th align="center" rowspan="1" colspan="1">Value of <italic>p</italic><sup>1</sup></th><th align="center" rowspan="1" colspan="1">Before observation</th><th align="center" rowspan="1" colspan="1">After observation</th><th align="center" rowspan="1" colspan="1">Value of <italic>p</italic><sup>2</sup></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">SDNN [ms]</td><td align="center" rowspan="1" colspan="1">118 &#x000b1;30</td><td align="center" rowspan="1" colspan="1">119.5 &#x000b1;31</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">124 &#x000b1;32</td><td align="center" rowspan="1" colspan="1">123 &#x000b1;25</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">LF [ms<sup>2</sup>/Hz]</td><td align="center" rowspan="1" colspan="1">532 &#x000b1;601</td><td align="center" rowspan="1" colspan="1">440 &#x000b1;572</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">339 &#x000b1;211</td><td align="center" rowspan="1" colspan="1">699 &#x000b1;1112</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">HF [ms<sup>2</sup>/Hz]</td><td align="center" rowspan="1" colspan="1">392 &#x000b1;493</td><td align="center" rowspan="1" colspan="1">482 &#x000b1;535</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">225 &#x000b1;154</td><td align="center" rowspan="1" colspan="1">386 &#x000b1;540</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">LF/HF</td><td align="center" rowspan="1" colspan="1">1.91 &#x000b1;1.11</td><td align="center" rowspan="1" colspan="1">1.07 &#x000b1;0.63</td><td align="center" rowspan="1" colspan="1">0.0001</td><td align="center" rowspan="1" colspan="1">2.2 &#x000b1;1.6</td><td align="center" rowspan="1" colspan="1">2.46 &#x000b1;1.6</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">0.0038</td></tr><tr><td align="left" rowspan="1" colspan="1">TO (%)</td><td align="center" rowspan="1" colspan="1">&#x02013;1.51 &#x000b1;3.12</td><td align="center" rowspan="1" colspan="1">&#x02013;2.14 &#x000b1;2.69</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">&#x02013;1.31 &#x000b1;1.13</td><td align="center" rowspan="1" colspan="1">&#x02013;1.99 &#x000b1;1.50</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">TS [ms/RR interval]</td><td align="center" rowspan="1" colspan="1">9.04 &#x000b1;10.29</td><td align="center" rowspan="1" colspan="1">8.88 &#x000b1;7.16</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">5.43 &#x000b1;5.01</td><td align="center" rowspan="1" colspan="1">5.98 &#x000b1;3.23</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">NS</td></tr></tbody></table><table-wrap-foot><fn><p>Data presented are mean values &#x000b1; SD; statistical significance: p &#x0003c; 0.05; NS &#x02013; non-significant, SDNN &#x02013; standard deviation of all normal RR intervals; LF &#x02013; low frequency, HF &#x02013; high frequency; low-to-high frequency ratio; TO &#x02013; turbulence onset, TS &#x02013; turbulence slope.</p></fn></table-wrap-foot></table-wrap></sec><sec id="S20011"><title>Effectiveness of Nordic walking training</title><p>Nordic walking training resulted in a significant improvement in functional capacity assessed by peak VO<sub>2</sub> (16.98 &#x000b1;4.02 vs. 19.70 &#x000b1;4.36 ml/kg/min, <italic>p</italic> &#x0003c; 0.0001). In the CG we did not observe significant changes in peak VO<sub>2</sub> (17.90 &#x000b1;3.61 vs. 17.72 &#x000b1;3.95, <italic>p</italic> = 0.7805). Between-group analysis showed that the differences between TG and CG were statistically significant in terms of &#x00394;peak VO<sub>2</sub>, after adjustment for age and NYHA class (<italic>p</italic> = 0.0081) (<xref ref-type="fig" rid="F0001">Figure 1</xref>).</p><fig id="F0001" position="float"><label>Figure 1</label><caption><p>Changes in peak oxygen consumption (peak VO<sub>2</sub>) within training and control groups and between those groups</p></caption><graphic xlink:href="AMS-11-26367-g001"/></fig><p>Additionally, an inverse correlation was found between the decrease in &#x00394;LF/HF and the increase in &#x00394;peak VO<sub>2</sub> (<italic>R</italic> = &#x02013;0.3830, <italic>p</italic> = 0.0211) only in the TG (<xref ref-type="fig" rid="F0002">Figure 2</xref>). There was no correlation observed between these parameters in the CG (<italic>R</italic> = &#x02013;0.2163, <italic>p</italic> = 0.4387) (<xref ref-type="fig" rid="F0003">Figure 3</xref>).</p><fig id="F0002" position="float"><label>Figure 2</label><caption><p>Correlation between the change in peak oxygen consumption (&#x00394;peak VO<sub>2</sub>) and the change in low-to-high frequency ratio (&#x00394;LF/HF) in training group</p></caption><graphic xlink:href="AMS-11-26367-g002"/></fig><fig id="F0003" position="float"><label>Figure 3</label><caption><p>Correlation between the change in peak oxygen consumption (&#x00394;peak VO<sub>2</sub>) and the change in low-to-high frequency ratio (&#x00394;LF/HF) in control group</p></caption><graphic xlink:href="AMS-11-26367-g003"/></fig></sec></sec><sec sec-type="discussion" id="S0012"><title>Discussion</title><p>The main and novel finding of our study is that in CHF patients, home-based telemonitored Nordic walking training leads to the improvement of the balance of the ANS components assessed by LF/HF ratio and physical capacity evaluated by peak VO<sub>2</sub> in CPET. Moreover, the changes in peak VO<sub>2</sub> were significantly correlated with the changes in LF/HF ratio. In the TG, individual ANS parameters (SDNN, LF, HF) indicated positive yet non-significant statistical trends (decreased LF, increased HF), but in consequence, final balance of the ANS components (LF/HF) improved significantly.</p><p>For this reason, it is clear that the positive yet statistically non-significant changes of individual ANS parameters which caused a significant influence on the parasympathetic-sympathetic balance can be considered as one of the pleiotropic (i.e. multifactorial, broader) effects of Nordic walking training. These favourable changes were not observed in the CG. The HRT did not change significantly in either the training or the control group. It needs to be stressed that before and after the 8-week Nordic walking training/observation the TO and TS values were within the norm in both groups. The varied response to Nordic walking in terms of HRV and HRT can be explained by the fact that ANS indices analyzed in this study reflect different components of the ANS. While HRV reflects its spontaneous activity, HRT reflects the response of baroreflex receptor activity provoked by ventricular premature beats. So far, only one study focused on HRT after rehabilitation in CHF patients has been published and our observations are concordant with this specific study [<xref rid="CIT0019" ref-type="bibr">19</xref>].</p><p>It is clear that the ANS reaction to exercise training depends on the ANS dysfunction level prior to rehabilitation. For the results of our study it is essential that both groups were comparable in terms of analyzed parameters responsible for ANS activity precisely prior to the intervention and, for this reason, the improvement of parasympathetic-sympathetic balance after the rehabilitation in the TG as compared to the CG can be considered reliable and valid.</p><p>Few studies of CHF patients showed favourable effects on HRV after cardiac rehabilitation. Although published studies have evaluated the influence of exercise training on ANS, the influence of Nordic walking training on HRV and HRT has not yet been assessed in any study. The majority of published data indicates that endurance aerobic training significantly increases SDNN [<xref rid="CIT0020" ref-type="bibr">20</xref>&#x02013;<xref rid="CIT0023" ref-type="bibr">23</xref>]. Nevertheless, Selig <italic>et al</italic>. did not find any difference after moderate-intensity resistance exercise training in the time domain (SDNN) but observed significant improvement in LF/HF ratio [<xref rid="CIT0024" ref-type="bibr">24</xref>]. Our results are consistent with these outcomes. Coats <italic>et al</italic>., on the other hand, reported that exercise training improved exercise tolerance, increased HRV and reduced whole body norepinephrine spillover in CHF patients [<xref rid="CIT0021" ref-type="bibr">21</xref>]. Kiilavuori <italic>et al</italic>. showed that rehabilitation increased high frequency HRV in patients suffering from CHF [<xref rid="CIT0025" ref-type="bibr">25</xref>]. Their findings support the hypothesis that exercise training modulates autonomic derangement in CHF by increasing parasympathetic tone. Radaelli <italic>et al</italic>. found that sympathetic modulation of peripheral vessels is diminished in CHF but significantly improved following the rehabilitation [<xref rid="CIT0026" ref-type="bibr">26</xref>]. The training appears to impart beneficial changes in autonomic control in CHF patients through both increased sympathetic control of peripheral vessels and parasympathetic control of heart rate [<xref rid="CIT0026" ref-type="bibr">26</xref>].</p><p>Malfato <italic>et al</italic>. observed greater restoration of ANS responsiveness to vagal and sympathetic stimulation in CHF patients after 3 months of a low-intensity rehabilitation programme. Moreover, the authors reported significant improvement not only in ANS activity but also in peak VO<sub>2</sub> [<xref rid="CIT0027" ref-type="bibr">27</xref>]. In contrast to our study there was no correlation between the amount of improvement in exercise capability (expressed as % change in peak VO<sub>2</sub>) and the amount of change in autonomic responsiveness (expressed as changes in LF/HF during controlled respiration or during standing) [<xref rid="CIT0027" ref-type="bibr">27</xref>]. Also Murad <italic>et al</italic>. reported that the improvement in HRV did not correlate with measures of exercise capacity [<xref rid="CIT0028" ref-type="bibr">28</xref>]. Similarly, our study proved that there were no positive effects in patients who did not undergo the exercise training.</p><p>The studies conducted so far evaluated various parameters (time domain and/or frequency domain indices) reflecting ANS activity. Individual parameters have not always been improved, yet the sympathetic-parasympathetic balance was restored, which indicated that exercise training increases vagal tone and reduces sympathetic cardiac influence, resulting in the improvement in HRV. On the whole, all the studied exercise modalities such as supervised aerobic endurance and resistance training and home-based rehabilitation improved HRV among CHF patients [<xref rid="CIT0019" ref-type="bibr">19</xref>&#x02013;<xref rid="CIT0032" ref-type="bibr">32</xref>].</p><p>The findings to date imply that exercise training exerts an influence on HRV favourable modulation of sympathetic/parasympathetic balance (via increasing vagal modulation and decreasing sympathetic tone). Further research is needed to identify the training protocols which would produce optimal improvements in HRV and HRT. This research should encompass the assessment of the following variables: training type (endurance/resistance/strength/respiratory), intensity (aerobic/anaerobic), method (continuous/interval), duration (time of session), frequency (number of sessions per day/per week) application (systemic/regional), control (supervised/telesupervised/unsupervised), progression (consider low level initially/increase if tolerated) and setting (hospital/out-patient/home-based) [<xref rid="CIT0002" ref-type="bibr">2</xref>&#x02013;<xref rid="CIT0004" ref-type="bibr">4</xref>, <xref rid="CIT0011" ref-type="bibr">11</xref>, <xref rid="CIT0033" ref-type="bibr">33</xref>].</p><p>For this reason, additional studies comparing the influence of different training modalities on ANS activity on larger patient groups are necessary.</p><p>The limitations include the fact that our study was part of a single centre trial. Due to the nature of the intervention, the study was not blinded. The study group was not very large. Only a few women participated in the study; therefore our outcomes cannot be fully extrapolated to the female population.</p><p>The duration of Nordic walking training in our study was relatively short &#x02013; only 8 weeks. We did not exclude patients who underwent CABG, in whom afferent and efferent cardiac innervations might have been impaired. We also did not exclude patients suffering from diabetes mellitus and hypertension in whom ANS might have been affected by these diseases. Nevertheless, both training and control groups were comparable in terms of CABG, diabetes mellitus and hypertension.</p><p>In conclusion, Nordic walking showed positive effects as far as the parasympathetic-sympathetic balance in CHF patients of NYHA class II and III was concerned, yet no significant changes in HRT were observed. This positive balance change correlates with the improvement of physical capacity resulting from home-based telemonitored Nordic walking training modality. Our results demonstrate that different processes modulate HRV and HRT, which offers additional information about ANS activity. The 8-week Nordic walking training was nevertheless unsuccessful in terms of completely normalizing the ANS function.</p></sec></body><back><ack><title>Acknowledgments</title><p>The study was supported by the National Science Centre, Poland &#x02013; grant number NN404 107936.</p></ack><sec id="S0013"><title>Conflict of interest</title><p>The authors declare no conflict of interest.</p></sec><ref-list><title>References</title><ref id="CIT0001"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMurray</surname><given-names>JJ</given-names></name><name><surname>Adamopoulos</surname><given-names>S</given-names></name><name><surname>Anker</surname><given-names>SD</given-names></name><etal/></person-group><article-title>ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012</article-title><source>Eur Heart J</source><year>2012</year><volume>33</volume><fpage>1787</fpage><lpage>869</lpage><pub-id pub-id-type="pmid">22611136</pub-id></element-citation></ref><ref id="CIT0002"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasznicki</surname><given-names>J</given-names></name><name><surname>Drzewoski</surname><given-names>J</given-names></name></person-group><article-title>Heart failure in the diabetic population &#x02013; pathophysiology, diagnosis and management</article-title><source>Arch Med Sci</source><year>2014</year><volume>10</volume><fpage>546</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">25097587</pub-id></element-citation></ref><ref id="CIT0003"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lainscak</surname><given-names>M</given-names></name><name><surname>Letonja</surname><given-names>M</given-names></name><name><surname>Kovacic</surname><given-names>D</given-names></name><etal/></person-group><article-title>General public awareness of heart failure: results of questionnaire survey during Heart Failure Awareness Day 2011</article-title><source>Arch Med Sci</source><year>2014</year><volume>10</volume><fpage>355</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">24904672</pub-id></element-citation></ref><ref id="CIT0004"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anker</surname><given-names>MS</given-names></name><name><surname>von Haehling</surname><given-names>S</given-names></name><name><surname>Springer</surname><given-names>J</given-names></name><name><surname>Banach</surname><given-names>M</given-names></name><name><surname>Anker</surname><given-names>SD</given-names></name></person-group><article-title>Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology</article-title><source>Arch Med Sci</source><year>2013</year><volume>9</volume><fpage>166</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">23515589</pub-id></element-citation></ref><ref id="CIT0005"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Routledge</surname><given-names>FS</given-names></name><name><surname>Campbell</surname><given-names>TS</given-names></name><name><surname>McFetridge-Durdle</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Improvements in heart rate variability with exercise therapy</article-title><source>Can J Cardiol</source><year>2010</year><volume>26</volume><fpage>303</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">20548976</pub-id></element-citation></ref><ref id="CIT0006"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gademan</surname><given-names>MGJ</given-names></name><name><surname>Swenne</surname><given-names>CA</given-names></name><name><surname>Verwey</surname><given-names>HF</given-names></name><etal/></person-group><article-title>Effect of exercise training on autonomic derangement and neurohumoral activation in chronic heart failure</article-title><source>J Cardiac Fail</source><year>2007</year><volume>13</volume><fpage>294</fpage><lpage>303</lpage></element-citation></ref><ref id="CIT0007"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braith</surname><given-names>RW</given-names></name><name><surname>Edwards</surname><given-names>DG</given-names></name></person-group><article-title>Neurohormonal abnormalities in heart failure: impact of exercise training</article-title><source>Congest Heart Fail</source><year>2003</year><volume>9</volume><fpage>70</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12671337</pub-id></element-citation></ref><ref id="CIT0008"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tschentscher</surname><given-names>M</given-names></name><name><surname>Niederseer</surname><given-names>D</given-names></name><name><surname>Niebauer</surname><given-names>J</given-names></name></person-group><article-title>Health benefits of Nordic walking: a systematic review</article-title><source>Am J Prev Med</source><year>2013</year><volume>44</volume><fpage>76</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">23253654</pub-id></element-citation></ref><ref id="CIT0009"><label>9</label><element-citation publication-type="journal"><collab>Task Force of The European Society of Cardiology and The North American Society of Pacing and Electrophysiology. Heart rate variability</collab><article-title>Standards of measurement, physiological interpretation, and clinical use</article-title><source>Eur Heart J</source><year>1996</year><volume>17</volume><fpage>354</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">8737210</pub-id></element-citation></ref><ref id="CIT0010"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piotrowicz</surname><given-names>E</given-names></name><name><surname>Zielinski</surname><given-names>T</given-names></name><name><surname>Bodalski</surname><given-names>R</given-names></name><etal/></person-group><article-title>Home-based telemonitored Nordic walking training is well accepted, safe, effective and has high adherence among heart failure patients, including those with cardiovascular implantable electronic devices &#x02013; a randomized controlled study</article-title><source>Eur J Prev Cardiol</source><year>2015</year><volume>22</volume><fpage>1368</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">25261268</pub-id></element-citation></ref><ref id="CIT0011"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piepoli</surname><given-names>MF</given-names></name><name><surname>Conraads</surname><given-names>V</given-names></name><name><surname>Corra</surname><given-names>U</given-names></name><etal/></person-group><article-title>Exercise training in heart failure: from theory to practice. A consensus document of the HFA and the EACPR</article-title><source>Eur J Heart Fail</source><year>2011</year><volume>13</volume><fpage>347</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">21436360</pub-id></element-citation></ref><ref id="CIT0012"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>G</given-names></name><name><surname>Malik</surname><given-names>M</given-names></name><name><surname>Barthel</surname><given-names>P</given-names></name><etal/></person-group><article-title>Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction</article-title><source>Lancet</source><year>1999</year><volume>353</volume><fpage>1390</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10227219</pub-id></element-citation></ref><ref id="CIT0013"><label>13</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Balady</surname><given-names>GJ</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Williams</surname><given-names>MA</given-names></name></person-group><article-title>Medical evaluation and exercise testing</article-title><source>Guidelins for Cardiac Rehabilitation and Secondary Prevention Programs</source><year>2004</year><publisher-name>Champaign (IL), Human Kinetics</publisher-name><fpage>79</fpage></element-citation></ref><ref id="CIT0014"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piepoli</surname><given-names>MF</given-names></name><name><surname>Corr&#x000e1;</surname><given-names>U</given-names></name><name><surname>Agostoni</surname><given-names>PG</given-names></name><etal/></person-group><article-title>Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation Part II: How to perform cardiopulmonary exercise testing in chronic heart failure</article-title><source>Eur J Cardiovasc Prev Rehabil</source><year>2006</year><volume>13</volume><fpage>300</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">16926657</pub-id></element-citation></ref><ref id="CIT0015"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borg</surname><given-names>GA</given-names></name></person-group><article-title>Psychophysical bases of perceived exertion</article-title><source>Med Sci Sports Exerc</source><year>1982</year><volume>14</volume><fpage>377</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">7154893</pub-id></element-citation></ref><ref id="CIT0016"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piotrowicz</surname><given-names>E</given-names></name></person-group><article-title>How to do telerehabilitation in heart failure patients</article-title><source>Cardiol J</source><year>2012</year><volume>19</volume><fpage>243</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">22641542</pub-id></element-citation></ref><ref id="CIT0017"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piotrowicz</surname><given-names>E</given-names></name><name><surname>Baranowski</surname><given-names>R</given-names></name><name><surname>Bilinska</surname><given-names>M</given-names></name><etal/></person-group><article-title>A new model of home-based telemonitored cardiac rehabilitation in patients with heart failure: effectiveness, quality of life, and adherence</article-title><source>Eur J Heart Fail</source><year>2010</year><volume>12</volume><fpage>164</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">20042423</pub-id></element-citation></ref><ref id="CIT0018"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piotrowicz</surname><given-names>E</given-names></name><name><surname>Jasionowska</surname><given-names>A</given-names></name><name><surname>Banaszak-Bednarczyk</surname><given-names>M</given-names></name><etal/></person-group><article-title>ECG telemonitoring during home-based cardiac rehabilitation in heart failure patients</article-title><source>J Telemed Telecare</source><year>2012</year><volume>18</volume><fpage>193</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22604276</pub-id></element-citation></ref><ref id="CIT0019"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piotrowicz</surname><given-names>E</given-names></name><name><surname>Baranowski</surname><given-names>R</given-names></name><name><surname>Piotrowska</surname><given-names>M</given-names></name><name><surname>Zieli&#x00144;ski</surname><given-names>T</given-names></name><name><surname>Piotrowicz</surname><given-names>R</given-names></name></person-group><article-title>Variable effects of physical training of heart rate variability, heart rate recovery, and heart rate turbulence in chronic heart failure</article-title><source>Pacing Clin Electrophysiol</source><year>2009</year><volume>32</volume><issue>Suppl. 1</issue><fpage>S113</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">19250071</pub-id></element-citation></ref><ref id="CIT0020"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adamopoulos</surname><given-names>S</given-names></name><name><surname>Ponikowski</surname><given-names>P</given-names></name><name><surname>Cerquetani</surname><given-names>E</given-names></name><etal/></person-group><article-title>Circadian pattern of heart rate variability in chronic heart failure patients. Effects of physical training</article-title><source>Eur Heart J</source><year>1995</year><volume>16</volume><fpage>1380</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">8746907</pub-id></element-citation></ref><ref id="CIT0021"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coats</surname><given-names>AJ</given-names></name><name><surname>Adamopoulos</surname><given-names>S</given-names></name><name><surname>Radaelli</surname><given-names>A</given-names></name><etal/></person-group><article-title>Controlled trial of physical training in chronic heart failure, Exercise performance, hemodynamics, ventilation and autonomic function</article-title><source>Circulation</source><year>1992</year><volume>85</volume><fpage>2119</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">1591831</pub-id></element-citation></ref><ref id="CIT0022"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsen</surname><given-names>AI</given-names></name><name><surname>Gjesdal</surname><given-names>K</given-names></name><name><surname>Hall</surname><given-names>C</given-names></name><etal/></person-group><article-title>Effect of exercise training in patients with heart failure: a pilot study on autonomic balance assessed by heart rate variability</article-title><source>Eur J Cardiovasc Prev Rehabil</source><year>2004</year><volume>11</volume><fpage>162</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15187821</pub-id></element-citation></ref><ref id="CIT0023"><label>23</label><element-citation publication-type="journal"><collab>European Heart Failure Training Group</collab><article-title>Experience from controlled trials of physical training in chronic heart failure. Protocol and patient factors in effectiveness in the improvement in exercise tolerance</article-title><source>Eur Heart J</source><year>1998</year><volume>19</volume><fpage>466</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">9568451</pub-id></element-citation></ref><ref id="CIT0024"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selig</surname><given-names>SE</given-names></name><name><surname>Carey</surname><given-names>MF</given-names></name><name><surname>Menzies</surname><given-names>DG</given-names></name><etal/></person-group><article-title>Moderate-intensity resistance exercise training in patients with chronic heart failure improves strength, endurance, heart rate variability, and forearm blood flow</article-title><source>J Card Fail</source><year>2004</year><volume>10</volume><fpage>21</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">14966771</pub-id></element-citation></ref><ref id="CIT0025"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiilavuori</surname><given-names>K</given-names></name><name><surname>Toivonen</surname><given-names>L</given-names></name><name><surname>Naveri</surname><given-names>H</given-names></name><etal/></person-group><article-title>Reversal of autonomic derangements by physical training in chronic heart failure assessed by heart rate variability</article-title><source>Eur Heart J</source><year>1995</year><volume>16</volume><fpage>490</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">7671894</pub-id></element-citation></ref><ref id="CIT0026"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radaelli</surname><given-names>A</given-names></name><name><surname>Coats</surname><given-names>AJ</given-names></name><name><surname>Leuzzi</surname><given-names>S</given-names></name></person-group><article-title>Physical training enhances sympathetic and parasympathetic control of heart rate and peripheral vessels in chronic heart failure</article-title><source>Clin Sci (Lond)</source><year>1996</year><volume>91</volume><issue>Suppl</issue><fpage>92</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">8813840</pub-id></element-citation></ref><ref id="CIT0027"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malfatto</surname><given-names>G</given-names></name><name><surname>Branzi</surname><given-names>G</given-names></name><name><surname>Riva</surname><given-names>B</given-names></name><etal/></person-group><article-title>Recovery of cardiac autonomic responsiveness with low-intensity physical training in patients with chronic heart failure</article-title><source>Eur J Heart Fail</source><year>2002</year><volume>4</volume><fpage>159</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">11959044</pub-id></element-citation></ref><ref id="CIT0028"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murad</surname><given-names>K</given-names></name><name><surname>Brubaker</surname><given-names>PH</given-names></name><name><surname>Fitzgerald</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Exercise training improves heart rate variability in older patients with heart failure: a randomized, controlled, single-blinded trial</article-title><source>Congest Heart Fail</source><year>2012</year><volume>18</volume><fpage>192</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22536936</pub-id></element-citation></ref><ref id="CIT0029"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iellamo</surname><given-names>F</given-names></name><name><surname>Manzi</surname><given-names>V</given-names></name><name><surname>Caminiti</surname><given-names>G</given-names></name><etal/></person-group><article-title>Dose-response relationship of baroreflex sensitivity and heart rate variability to individually-tailored exercise training in patients with heart failure</article-title><source>Int J Cardiol</source><year>2013</year><volume>166</volume><fpage>334</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">22078985</pub-id></element-citation></ref><ref id="CIT0030"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pietil&#x000e4;</surname><given-names>M</given-names></name><name><surname>Malminiemi</surname><given-names>K</given-names></name><name><surname>Vesalainen</surname><given-names>R</given-names></name><etal/></person-group><article-title>Exercise training in chronic heart failure: beneficial effects on cardiac (11)C-hydroxyephedrine PET, autonomic nervous control, and ventricular repolarization</article-title><source>J Nucl Med</source><year>2002</year><volume>43</volume><fpage>773</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12050322</pub-id></element-citation></ref><ref id="CIT0031"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponikowski</surname><given-names>P</given-names></name><name><surname>Chua</surname><given-names>TP</given-names></name><name><surname>Piepoli</surname><given-names>M</given-names></name><etal/></person-group><article-title>Ventilatory response to exercise correlates with impaired heart rate variability in patients with chronic congestive heart failure</article-title><source>Am J Cardiol</source><year>1998</year><volume>82</volume><fpage>338</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">9708664</pub-id></element-citation></ref><ref id="CIT0032"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>CC</given-names></name><name><surname>Viljoen</surname><given-names>M</given-names></name><name><surname>Janse van Rensburg</surname><given-names>DCJ</given-names></name><etal/></person-group><article-title>Heart rate variability assessment of the effect of physical training on autonomic cardiac control</article-title><source>Ann Noninvasive Electrocardiol</source><year>2012</year><volume>17</volume><fpage>219</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">22816541</pub-id></element-citation></ref><ref id="CIT0033"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piotrowicz</surname><given-names>E</given-names></name><name><surname>Orzechowski</surname><given-names>P</given-names></name><name><surname>Chrapowicka</surname><given-names>A</given-names></name><name><surname>Piotrowicz</surname><given-names>R</given-names></name></person-group><article-title>How should we advise heart failure patients on exercise and what should we tell them?</article-title><source>Curr Heart Fail Rep</source><year>2014</year><volume>11</volume><fpage>274</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">24890900</pub-id></element-citation></ref></ref-list></back></article>